Skip to main content
. 2017 Sep 14;8(63):107237–107257. doi: 10.18632/oncotarget.20883

Table 6. Information of search methods and criteria of inclusion and exclusion.

Methods Information
Search strategy 4 search engines, including PubMed, EMBASE, Web of
Science and Cochrane Database of Systematic Reviews
Search deadline 15 April, 2017
Search terms mir and hepatocellular carcinoma
Inclusion criteria (1) Patients with hepatocellular carcinoma;
(2) Expression of miRNAs and survival outcome in
tissue, plasma or serum were measured;
(3) At least, one of survival curves about overall survival
(OS), cause-specific survival (CSS), disease-free survival
(DFS), recurrence-free survival (RFS), progression-free
survival (PFS) and metastasis-free survival (MFS)
was measured, with or without the HR or 95% CI;
(4) Full text articles published in English
Exclusion criteria (1) Reviews, letters or laboratory studies without
original data and retracted articles;
(2) Frequency of studies estimating prognostic value
of miRNAs ≤ 2 in tissue;
(3) Studies which cannot be merged;
(4) If more than one article had been published on the
identical study cohort, only the most comprehensive
study was selected for the present meta-analysis